PubMed中文版
| PubMed ID | 32203698 |
|---|---|
| 发表日期 | 2020-03-20 |
| 作者 | Abou-Alfa GK, Sahai V, Hollebecque A, Vaccaro G, Melisi D, Al-Rajabi R, Paulson AS, Borad MJ, Gallinson D, Murphy AG, Oh DY, Dotan E, Catenacci DV, Van Cutsem E, Ji T, Lihou CF, Zhen H, Féliz L, Vogel A. |
| 文献标题 | Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study. |
| 原始出处 | Lancet Oncol |
| 影响因子 | 35.9 期刊引文指标 8.68 |
| PubMed ID | 30779531 |
|---|---|
| 发表日期 | 2019-02-16 |
| 作者 | Motzer RJ, Penkov K, Haanen J, Rini B, Albiges L, Campbell MT, Venugopal B, Kollmannsberger C, Negrier S, Uemura M, Lee JL, Vasiliev A, Miller WH, Gurney H, Schmidinger M, Larkin J, Atkins MB, Bedke J, Alekseev B, Wang J, Mariani M, Robbins PB, Chudnovsky A, Fowst C, Hariharan S, Huang B, di Pietro A, Choueiri TK. |
| 文献标题 | Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma. |
| 原始出处 | N Engl J Med |
| 影响因子 | 78.5 期刊引文指标 23.3 |
| PubMed ID | 29442540 |
|---|---|
| 发表日期 | 2018-02-14 |
| 作者 | Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, Chau I, Ernstoff MS, Gardner JM, Ginex P, Hallmeyer S, Holter Chakrabarty J, Leighl NB, Mammen JS, McDermott DF, Naing A, Nastoupil LJ, Phillips T, Porter LD, Puzanov I, Reichner CA, Santomasso BD, Seigel C, Spira A, Suarez-Almazor ME, Wang Y, Weber JS, Wolchok JD, Thompson JA, National Comprehensive Cancer Network. |
| 文献标题 | Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline. |
| 原始出处 | J Clin Oncol |
| 影响因子 | 41.9 期刊引文指标 6.68 |
| PubMed ID | 28734759 |
|---|---|
| 发表日期 | 2017-07-19 |
| 作者 | Overman MJ, McDermott R, Leach JL, Lonardi S, Lenz HJ, Morse MA, Desai J, Hill A, Axelson M, Moss RA, Goldberg MV, Cao ZA, Ledeine JM, Maglinte GA, Kopetz S, André T. |
| 文献标题 | Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. |
| 原始出处 | Lancet Oncol |
| 影响因子 | 35.9 期刊引文指标 8.68 |
| PubMed ID | 27999003 |
|---|---|
| 发表日期 | 2017-01-01 |
| 作者 | Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, Sosenko JM, Ziegler D. |
| 文献标题 | Diabetic Neuropathy: A Position Statement by the American Diabetes Association. |
| 原始出处 | Diabetes Care |
| 影响因子 | 16.6 期刊引文指标 4.44 |
| PubMed ID | 27959700 |
|---|---|
| 发表日期 | 2016-12-06 |
| 作者 | Mok TS, Wu Y-L, Ahn M-J, Garassino MC, Kim HR, Ramalingam SS, Shepherd FA, He Y, Akamatsu H, Theelen WS, Lee CK, Sebastian M, Templeton A, Mann H, Marotti M, Ghiorghiu S, Papadimitrakopoulou VA, AURA3 Investigators. |
| 文献标题 | Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer. |
| 原始出处 | N Engl J Med |
| 影响因子 | 78.5 期刊引文指标 23.3 |
| PubMed ID | 27718784 |
|---|---|
| 发表日期 | 2016-10-08 |
| 作者 | Ferris RL, Blumenschein G, Fayette J, Guigay J, Colevas AD, Licitra L, Harrington K, Kasper S, Vokes EE, Even C, Worden F, Saba NF, Iglesias Docampo LC, Haddad R, Rordorf T, Kiyota N, Tahara M, Monga M, Lynch M, Geese WJ, Kopit J, Shaw JW, Gillison ML. |
| 文献标题 | Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. |
| 原始出处 | N Engl J Med |
| 影响因子 | 78.5 期刊引文指标 23.3 |
| PubMed ID | 26115796 |
|---|---|
| 发表日期 | 2015-06-23 |
| 作者 | Ribas A, Puzanov I, Dummer R, Schadendorf D, Hamid O, Robert C, Hodi FS, Schachter J, Pavlick AC, Lewis KD, Cranmer LD, Blank CU, O'Day SJ, Ascierto PA, Salama AK, Margolin KA, Loquai C, Eigentler TK, Gangadhar TC, Carlino MS, Agarwala SS, Moschos SJ, Sosman JA, Goldinger SM, Shapira-Frommer R, Gonzalez R, Kirkwood JM, Wolchok JD, Eggermont A, Li XN, Zhou W, Zernhelt AM, Lis J, Ebbinghaus S, Kang SP, Daud A. |
| 文献标题 | Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial. |
| 原始出处 | Lancet Oncol |
| 影响因子 | 35.9 期刊引文指标 8.68 |
| PubMed ID | 26028255 |
|---|---|
| 发表日期 | 2015-05-30 |
| 作者 | Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, Biedrzycki B, Donehower RC, Zaheer A, Fisher GA, Crocenzi TS, Lee JJ, Duffy SM, Goldberg RM, de la Chapelle A, Koshiji M, Bhaijee F, Huebner T, Hruban RH, Wood LD, Cuka N, Pardoll DM, Papadopoulos N, Kinzler KW, Zhou S, Cornish TC, Taube JM, Anders RA, Eshleman JR, Vogelstein B, Diaz LA. |
| 文献标题 | PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. |
| 原始出处 | N Engl J Med |
| 影响因子 | 78.5 期刊引文指标 23.3 |
| PubMed ID | 25693012 |
|---|---|
| 发表日期 | 2015-02-01 |
| 作者 | Swain SM, Baselga J, Kim SB, Ro J, Semiglazov V, Campone M, Ciruelos E, Ferrero JM, Schneeweiss A, Heeson S, Clark E, Ross G, Benyunes MC, Cortés J, CLEOPATRA Study Group. |
| 文献标题 | Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. |
| 原始出处 | N Engl J Med |
| 影响因子 | 78.5 期刊引文指标 23.3 |
| PubMed ID | 25601342 |
|---|---|
| 发表日期 | 2015-01-16 |
| 作者 | Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, Bogart J, Hu C, Forster K, Magliocco A, Kavadi V, Garces YI, Narayan S, Iyengar P, Robinson C, Wynn RB, Koprowski C, Meng J, Beitler J, Gaur R, Curran W, Choy H. |
| 文献标题 | Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. |
| 原始出处 | Lancet Oncol |
| 影响因子 | 35.9 期刊引文指标 8.68 |
| PubMed ID | 25428504 |
|---|---|
| 发表日期 | 2014-11-01 |
| 作者 | Herbst RS, Soria JC, Kowanetz M, Fine GD, Hamid O, Gordon MS, Sosman JA, McDermott DF, Powderly JD, Gettinger SN, Kohrt HE, Horn L, Lawrence DP, Rost S, Leabman M, Xiao Y, Mokatrin A, Koeppen H, Hegde PS, Mellman I, Chen DS, Hodi FS. |
| 文献标题 | Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. |
| 原始出处 | Nature |
| 影响因子 | 48.5 期刊引文指标 11.12 |
| PubMed ID | 23589827 |
|---|---|
| 发表日期 | 2013-04-01 |
| 作者 | Günzel D, Yu AS. |
| 文献标题 | Claudins and the modulation of tight junction permeability. |
| 原始出处 | Physiol Rev |
| 影响因子 | 28.7 期刊引文指标 5.48 |
| PubMed ID | 22149875 |
|---|---|
| 发表日期 | 2011-12-07 |
| 作者 | Baselga J, Cortés J, Kim SB, Im SA, Hegg R, Im YH, Roman L, Pedrini JL, Pienkowski T, Knott A, Clark E, Benyunes MC, Ross G, Swain SM, CLEOPATRA Study Group. |
| 文献标题 | Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer. |
| 原始出处 | N Engl J Med |
| 影响因子 | 78.5 期刊引文指标 23.3 |
| PubMed ID | 21449784 |
|---|---|
| 发表日期 | 2011-03-01 |
| 作者 | Bacon BR, Gordon SC, Lawitz E, Marcellin P, Vierling JM, Zeuzem S, Poordad F, Goodman ZD, Sings HL, Boparai N, Burroughs M, Brass CA, Albrecht JK, Esteban R, HCV RESPOND-2 Investigators. |
| 文献标题 | Boceprevir for previously treated chronic HCV genotype 1 infection. |
| 原始出处 | N Engl J Med |
| 影响因子 | 78.5 期刊引文指标 23.3 |
| PubMed ID | 21306238 |
|---|---|
| 发表日期 | 2011-02-01 |
| 作者 | Yao JC, Shah MH, Ito T, Bohas CL, Wolin EM, Van Cutsem E, Hobday TJ, Okusaka T, Capdevila J, de Vries EG, Tomassetti P, Pavel ME, Hoosen S, Haas T, Lincy J, Lebwohl D, Öberg K, RAD001 in Advanced Neuroendocrine Tumors, Third Trial (RADIANT-3) Study Group. |
| 文献标题 | Everolimus for advanced pancreatic neuroendocrine tumors. |
| 原始出处 | N Engl J Med |
| 影响因子 | 78.5 期刊引文指标 23.3 |
| PubMed ID | 20516446 |
|---|---|
| 发表日期 | 2010-06-01 |
| 作者 | Brahmer JR, Drake CG, Wollner I, Powderly JD, Picus J, Sharfman WH, Stankevich E, Pons A, Salay TM, McMiller TL, Gilson MM, Wang C, Selby M, Taube JM, Anders R, Chen L, Korman AJ, Pardoll DM, Lowy I, Topalian SL. |
| 文献标题 | Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. |
| 原始出处 | J Clin Oncol |
| 影响因子 | 41.9 期刊引文指标 6.68 |
| PubMed ID | 19487381 |
|---|---|
| 发表日期 | 2009-06-01 |
| 作者 | Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Oudard S, Negrier S, Szczylik C, Pili R, Bjarnason GA, Garcia-del-Muro X, Sosman JA, Solska E, Wilding G, Thompson JA, Kim ST, Chen I, Huang X, Figlin RA. |
| 文献标题 | Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. |
| 原始出处 | J Clin Oncol |
| 影响因子 | 41.9 期刊引文指标 6.68 |
| PubMed ID | 17493201 |
|---|---|
| 发表日期 | 2007-05-01 |
| 作者 | Inouye SK, Studenski S, Tinetti ME, Kuchel GA. |
| 文献标题 | Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept. |
| 原始出处 | J Am Geriatr Soc |
| 影响因子 | 4.5 期刊引文指标 1.27 |
| PubMed ID | 12716821 |
|---|---|
| 发表日期 | 2003-05-01 |
| 作者 | Vinik AI, Maser RE, Mitchell BD, Freeman R. |
| 文献标题 | Diabetic autonomic neuropathy. |
| 原始出处 | Diabetes Care |
| 影响因子 | 16.6 期刊引文指标 4.44 |